JP Morgan Chase’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-517,494
| Closed | -$7.84M | – | 5952 |
|
|
2019
Q4 | $7.84M | Buy |
517,494
+49,424
| +11% | +$427K | ﹤0.01% | 2325 |
|
|
2019
Q3 | $2.99M | Sell |
468,070
-314,153
| -40% | -$2.62M | ﹤0.01% | 3130 |
|
|
2019
Q2 | $7.03M | Buy |
782,223
+338,828
| +76% | +$3.65M | ﹤0.01% | 2372 |
|
|
2019
Q1 | $6.01M | Sell |
443,395
-50,178
| -10% | -$418K | ﹤0.01% | 2450 |
|
|
2018
Q4 | $3.55M | Sell |
493,573
-218,680
| -31% | -$2.39M | ﹤0.01% | 2839 |
|
|
2018
Q3 | $7.76M | Buy |
712,253
+568,248
| +395% | +$5.73M | ﹤0.01% | 2408 |
|
|
2018
Q2 | $1.32M | Sell |
144,005
-61,544
| -30% | -$574K | ﹤0.01% | 3668 |
|
|
2018
Q1 | $1.64M | Sell |
205,549
-17,998
| -8% | -$392K | ﹤0.01% | 3391 |
|
|
2017
Q4 | $6.22M | Sell |
223,547
-6,578
| -3% | -$174K | ﹤0.01% | 2499 |
|
|
2017
Q3 | $6.1M | Sell |
230,125
-8,650
| -4% | -$226K | ﹤0.01% | 2404 |
|
|
2017
Q2 | $6.96M | Buy |
238,775
+208,105
| +679% | +$6.33M | ﹤0.01% | 2246 |
|
|
2017
Q1 | $1.05M | Sell |
30,670
-30,380
| -50% | -$980K | ﹤0.01% | 3388 |
|
|
2016
Q4 | $1.85M | Buy |
61,050
+50,900
| +501% | +$1.64M | ﹤0.01% | 3114 |
|
|
2016
Q3 | $343K | Buy |
10,150
+6,592
| +185% | +$212K | ﹤0.01% | 3527 |
|
|
2016
Q2 | $104K | Buy |
3,558
+3,500
| +6,034% | +$96.6K | ﹤0.01% | 3871 |
|
|
2016
Q1 | $1K | Buy |
58
+16
| +38% | +$393 | ﹤0.01% | 4602 |
|
|
2015
Q4 | $1K | Buy |
+42
| New | +$1.21K | ﹤0.01% | 4642 |
|
JP Morgan Chase's DERM Position: Q1 2020 in Review
JP Morgan Chase sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 517,494 shares — an estimated $7.84M sold.
JP Morgan Chase first reported a position in DERM in Q4 2015 and held it in 17 quarters. The position peaked at $7.84M in Q4 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- JP Morgan Chase reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- JP Morgan Chase sold 517,494 Dermira, Inc. shares in Q1 2020, an estimated $7.84M.
- JP Morgan Chase first reported a position in Dermira, Inc. in Q4 2015 and held it in 17 quarters.
- JP Morgan Chase's Dermira, Inc. position peaked at $7.84M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.